The Big Diabetes Lie

Natural Diabetes Treatment System

Get Instant Access

[1] Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136(5):664-72.

[2] Centers for Disease Control and Prevention. Diabetes projects. Available at: http://www.cdc. gov/diabetes/projects/cda2.htm. Accessed August 15, 2005.

[3] Karvonen M, Viik-Kajander M, Moltchanova E, et al. Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23(10): 1516-26.

[4] Rosenbauer J, Herzig P, von Kries R, et al. Temporal, seasonal, and geographical incidence patterns of type I diabetes mellitus in children under 5 years of age in Germany. Diabetologia 1999;42(9):1055-9.

[5] LaPorte REMM, Chang Y-F. Prevalence and incidence of insulin-dependent diabetes. Bethesda (MD): National Institutes of Health; 1995.

[6] Krischer JP, Cuthbertson DD, Greenbaum C. Male sex increases the risk of autoimmunity but not type 1 diabetes. Diabetes Care 2004;27(8):1985-90.

[7] Weets I, Van Autreve J, Van der Auwera BJ, et al. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia 2001;44(1):40-7.

[8] Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26(3):917-32.

[9] Icks A, Rosenbauer J, Haastert B, et al. Direct costs of pediatric diabetes care in Germany and their predictors. Exp Clin Endocrinol Diabetes 2004;112(6):302-9.

[10] Tamborlane WV, Ahern J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am 1997;44(2):285-300.

[11] Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986; 314(21):1360-8.

[12] Rosenberg L. In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells. Cell Transplant 1995;4(4):371-83.

[13] Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res 2001;56:69-89.

[14] Hamalainen AM, Knip M. Autoimmunity and familial risk of type 1 diabetes. Curr Diab Rep 2002;2(4):347-53.

[15] Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab 2004;89(12):6257-65.

[16] Guo D, Li M, Zhang Y, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004;36(8):837-41.

[17] Zheng W, She JX. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 2005;54(3):906-8.

[18] Yoon JW, Jun HS. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann N Y Acad Sci 2001;928:200-11.

[19] Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 2003;46(3):305-21.

[20] Durinovic-Bello I. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens. Autoimmunity 1998;27(3):159-77.

[21] Schatz D, Krischer J, Horne G, et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994;93(6):2403-7.

[22] Winter WE, Harris N, Schatz D. Immunological markers in the diagnosis and prediction of autoimmune type 1a diabetes. Clin Diabetes 2002;20(4):183-91.

[23] Lohmann T, Kellner K, Verlohren HJ, et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 2001;44(8):1005-10.

[24] Solimena M, Dirkx Jr R, Hermel J, et al. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 1996;15(9):2102-14.

[25] Atkinson MA. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 2005;54(5):1253-63.

[26] Olmos P, A'Hern R, Heaton DA, et al. The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988;31(10):747-50.

[27] Ziegler AG, Hummel M, Schenker M, et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48(3):460-8.

[28] Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996;39(7):807-12.

[29] Akerblom HK, Knip M, Simell O. From pathomechanisms to prediction, prevention and improved care of insulin-dependent diabetes mellitus in children. Ann Med 1997;29(5):383-5.

[30] Leslie RD, Elliott RB. Early environmental events as a cause of IDDM: evidence and implications. Diabetes 1994;43(7):843-50.

[31] Graves PM, Norris JM, Pallansch MA, et al. The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes 1997;46(2):161-8.

[32] Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978; 1(8055):57-60.

[33] Dahlquist GG, Ivarsson S, Lindberg B, et al. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: a population-based case-control study. Diabetes 1995;44(4): 408-13.

[34] Ginsberg-Fellner F, Witt ME, Yagihashi S, et al. Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 1984;27(Suppl): 87-9.

[35] Bodansky HJ, Grant PJ, Dean BM, et al. Islet-cell antibodies and insulin autoantibodies in association with common viral infections. Lancet 1986;2(8520):1351-3.

[36] Blom L, Nystrom L, Dahlquist G. The Swedish childhood diabetes study: vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991;34(3):176-81.

[37] Clarke WL, Shaver KA, Bright GM, et al. Autoimmunity in congenital rubella syndrome. J Pediatr 1984;104(3):370-3.

[38] Karounos DG, Wolinsky JS, Thomas JW. Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 1993;150(7):3080-5.

[39] Hyoty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM: Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995;44(6):652-7.

[40] Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995;346(8969):221-3.

[41] Viskari HR, Koskela P, Lonnrot M, et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 2000;23(3):414-6.

[42] Helmke K, Otten A, Willems WR, et al. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 1986;29(1):30-3.

[43] Champsaur HF, Bottazzo GF, Bertrams J, et al. Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus. J Pediatr 1982;100(1):15-20.

[44] Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49(8):1319—24.

[45] Schatz DA, Maclaren NK. Cow's milk and insulin-dependent diabetes mellitus: innocent until proven guilty. JAMA 1996;276(8):647-8.

[46] Norris JM, Beaty B, Klingensmith G, et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA 1996;276(8):609-14.

[47] Atkinson MA, Bowman MA, Kao KJ, et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993;329(25):1853-8.

[48] Karjalainen J, Martin JM, Knip M, et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992;327(5):302-7.

[49] Martin JM, Trink B, Daneman D, et al. Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann Med 1991;23(4):447-52.

[50] Borch-Johnsen K, Joner G, Mandrup-Poulsen T, et al. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus: a hypothesis. Lancet 1984;2(8411):1083-6.

[51] Gerstein HC. Cow's milk exposure and type I diabetes mellitus: a critical overview of the clinical literature. Diabetes Care 1994;17(1):13-9.

[52] Elliott RB, Martin JM. Dietary protein: a trigger of insulin-dependent diabetes in the BB rat? Diabetologia 1984;26(4):297-9.

[53] Coleman DL, Kuzava JE, Leiter EH. Effect of diet on incidence of diabetes in nonobese diabetic mice. Diabetes 1990;39(4):432-6.

[54] Pietropaolo M, Castano L, Babu S, et al. Islet cell autoantigen 69 kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993; 92(1):359-71.

[55] Wright AL. The rise of breastfeeding in the United States. Pediatr Clin North Am 2001;48(1):1 -12.

[56] Ivarsson SA, Mansson MU, Jakobsson IL. IgG antibodies to bovine serum albumin are not increased in children with IDDM. Diabetes 1995;44(11):1349-50.

[57] Scott FW, Marliss EB. Conference summary: diet as an environmental factor in development of insulin-dependent diabetes mellitus. Can J Physiol Pharmacol 1991;69(3):311-9.

[58] Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290(13):1713-20.

[59] Ziegler AG, Schmid S, Huber D, et al. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003;290(13):1721-8.

[60] Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358(9292):1500-3.

[61] Saggese G, Federico G, Balestri M, et al. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest 1989;12(5):329-35.

[62] Mathieu C, Casteels K, Waer M, et al. Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2. Transplant Proc 1998; 30(2):541.

[63] Pont A, Rubino JM, Bishop D, et al. Diabetes mellitus and neuropathy following Vacor ingestion in man. Arch Intern Med 1979;139(2):185-7.

[64] Schein PS, Alberti KG, Williamson DH. Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology 1971;89(3):827-34.

[65] Kostraba JN, Gay EC, Rewers M, et al. Nitrate levels in community drinking waters and risk of IDDM: an ecological analysis. Diabetes Care 1992;15(11):1505-8.

[66] Dahlquist GG, Blom LG, Persson LA, et al. Dietary factors and the risk of developing insulin dependent diabetes in childhood. BMJ 1990;300(6735):1302-6.

[67] Dahlquist GG, Patterson C, Soltesz G. Perinatal risk factors for childhood type 1 diabetes in Europe: the EURODIAB Substudy 2 Study Group. Diabetes Care 1999;22(10):1698-702.

[68] McKinney PA, Parslow R, Gurney K, et al. Antenatal risk factors for childhood diabetes mellitus: a case-control study of medical record data in Yorkshire, UK. Diabetologia 1997;40(8): 933-9.

[69] Patterson CC, Carson DJ, Hadden DR, et al. A case-control investigation of perinatal risk factors for childhood IDDM in Northern Ireland and Scotland. Diabetes Care 1994;17(5):376-81.

[70] Flood TM, Brink SJ, Gleason RE. Increased incidence of type I diabetes in children of older mothers. Diabetes Care 1982;5(6):571 -3.

[71] Blom L, Dahlquist G, Nystrom L, et al. The Swedish childhood diabetes study: social and perinatal determinants for diabetes in childhood. Diabetologia 1989;32(1):7-13.

[72] Dahlquist G, Kallen B. Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35(7):671 -5.

[73] Hummel M, Ziegler AG. Vaccines and the appearance of islet cell antibodies in offspring of diabetic parents: results from the BABY-DIAB Study. Diabetes Care 1996;19(12):1456-7.

[74] Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996;24(3):137-45.

[75] Todd JA. A protective role of the environment in the development of type 1 diabetes? Diabet Med 1991;8(10):906-10.

[76] Singh B. Stimulation of the developing immune system can prevent autoimmunity. J Autoimmun 2000;14(1):15-22.

[77] Black P. Why is the prevalence of allergy and autoimmunity increasing? Trends Immunol 2001; 22(7):354-5.

[78] Mallare JT, Cordice CC, Ryan BA, et al. Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus. Clin Pediatr (Phila) 2003;42(7):591-7.

[79] Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004;89(2):188-94.

[80] Murray L, editor. Physicians' Desk Reference. 59th edition. Montvale (NJ): Thompson; 2005.

[81] Dupre J, Behme MT, McDonald TJ. Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes. J Clin Endocrinol Metab 2004;89(7):3469-73.

[82] Heptulla RA, Rodriguez LM, Bomgaars L, et al. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes 2005;54(4):1100-7.

[83] Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004;144(5):660-1.

[84] Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2(1):49-56.

[85] Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28(1):186-212.

[86] McCrindle BW, Helden E, Cullen-Dean G, et al. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. Pediatr Res 2002;51(6): 715 -21.

[87] Type 1 Diabetes Study Group. Diabetes prevention trial: effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002;346(22):1685-91.

[88] Gale EA, Bingley PJ, Emmett CL, et al. European icotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004;363(9413):925-31.

[89] Julius MC, Schatz DA, Silverstein JH. The prevention of type I diabetes mellitus. Pediatr Ann 1999;28(9):585-8.

Was this article helpful?

0 0
Quick Weight Loss Action

Quick Weight Loss Action

Why Indulge In Self-Pity When You Can Do Something About Your Weight Now. Say Goodbye to Your Weight Problems That Have Only Make Your Life Nothing But Miserable. Have you often felt short-changed because of your weight or physical appearance?

Get My Free Ebook

Post a comment